Since we are strongly convinced about the diagnostic biomarker potential of TRPC3 and TRPC7 transcript abundancy in tumor specimens, targeted attempts via rapid-to-apply technologies such as RT-qPCR or target-amplification free CRISPR/Cas diagnostics instead of OMICS-acquisition would enable better applicability/dissemination potential of our markers. Here, TRPC7 is linked to neoplasm.